EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research Progress on the Strategies for Crossing the Blood–Brain Barrier

Li Qiao, Xiuwei Du, Hua Wang, Zhiyi Wang, Shijie Gao, Chun-Qin Zhao iD

Molecular Pharmaceutics · 07.10.2024 · 21 (10) · 4786-4803

DOI: 10.1021/acs.molpharmaceut.4c00447 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 04.09.2024. Verfasst von Li Qiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Centre, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Drug Delivery Systems. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 166 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Shandong Province, Science Foundation of Shandong University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, the incidence of brain diseases, such as central nervous system degenerative diseases, brain tumors, and cerebrovascular diseases, has increased. However, the blood-brain barrier (BBB) limits the effective delivery of drugs to brain disease areas. Therefore, the mainstream direction of new drug development for these diseases is to engineer drugs that can better cross the BBB to exert their effects in the brain. This paper reviews the research progress and application of the main trans-BBB drug delivery strategies (receptor/transporter-mediated BBB crossing, focused ultrasound to open the BBB, adenosine agonist reversible opening of the BBB, aromatic resuscitation, transnasal administration, cell-mediated trans-BBB crossing, and viral vector system-mediated brain drug delivery). Meanwhile, the potential applications, advantages, and disadvantages of these strategies for crossing the BBB are analyzed. Finally, the future development prospects of strategies for crossing the BBB are also discussed. These strategies have potential value for treating brain diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierDrug Delivery SystemsHumansAnimalsBiological TransportBrain DiseasesBrain

Stichwörter der Autor:innen

BBBbrain diseasesdrug delivery systemtrans-BBB strategies

Autor:innen und Institutionen

  • Experimental Centre, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China.
  • College of Intelligence and Information Engineering, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China.
  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China.

ORCID-Profile: Chun-Qin Zhao

Förderung

  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Shandong Province
  • Science Foundation of Shandong University of Traditional Chinese Medicine

Zitieren

APA

Qiao, L., Du, X., Wang, H., Wang, Z., Gao, S., & Zhao, C. Q. (2024). Research Progress on the Strategies for Crossing the Blood–Brain Barrier. Molecular Pharmaceutics, 21(10), 4786-4803. https://doi.org/10.1021/acs.molpharmaceut.4c00447

Vancouver

Qiao L, Du X, Wang H, Wang Z, Gao S, Zhao CQ. Research Progress on the Strategies for Crossing the Blood–Brain Barrier. Molecular Pharmaceutics. 2024;21(10):4786-4803. doi:10.1021/acs.molpharmaceut.4c00447

BibTeX
@article{Qiao2024,
  author = {Qiao, Li and Du, Xiuwei and Wang, Hua and Wang, Zhiyi and Gao, Shijie and Zhao, Chun-Qin},
  title = {Research Progress on the Strategies for Crossing the Blood–Brain Barrier},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {10},
  pages = {4786--4803},
  doi = {10.1021/acs.molpharmaceut.4c00447}
}
Kostenlos starten →